title: Brain natriuretic peptide: potential adjunct for cardiac risk assessment and management during treatment with experimental anticancer agents.
authors.affiliation: Pfizer Global Research and Development, Ann Arbor, MI, USA.
authors.forename: Mary L
authors.initials: ML
authors.lastname: Varterasian
authors.forename: Mark B
authors.initials: MB
authors.lastname: Meyer
authors.forename: Milton L
authors.initials: ML
authors.lastname: Pressler
authors.forename: Howard J
authors.initials: HJ
authors.lastname: Fingert
authors.forename: Patricia M
authors.initials: PM
authors.lastname: LoRusso
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D000970:Antineoplastic Agents / Q000009:adverse effects*; D015415:Biomarkers / Q000097:blood; D015507:Drugs, Investigational / Q000009:adverse effects*; D005260:Female; D006801:Humans; D008875:Middle Aged; D020097:Natriuretic Peptide, Brain / Q000097:blood*; D018570:Risk Assessment; D018487:Ventricular Dysfunction, Left / Q000097:blood / Q000139:chemically induced / Q000175:diagnosis
chemical_list: D000970:Antineoplastic Agents; D015415:Biomarkers; D015507:Drugs, Investigational; D020097:Natriuretic Peptide, Brain